Park Avenue Securities LLC Sells 768 Shares of Integer Holdings Co. (NYSE:ITGR)

Park Avenue Securities LLC reduced its stake in Integer Holdings Co. (NYSE:ITGR) by 12.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,288 shares of the medical equipment provider’s stock after selling 768 shares during the quarter. Park Avenue Securities LLC’s holdings in Integer were worth $617,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. North Growth Management Ltd. bought a new stake in shares of Integer in the fourth quarter valued at about $9,155,000. Public Employees Retirement Association of Colorado boosted its position in Integer by 3,260.1% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after acquiring an additional 276,944 shares during the last quarter. Norges Bank bought a new position in shares of Integer during the 4th quarter worth approximately $18,697,000. Congress Asset Management Co. MA raised its holdings in shares of Integer by 12.5% in the fourth quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock valued at $41,765,000 after purchasing an additional 46,776 shares during the last quarter. Finally, GSA Capital Partners LLP bought a new stake in shares of Integer in the third quarter worth $816,000. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Trading Down 0.2 %

Shares of Integer stock opened at $114.53 on Friday. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. Integer Holdings Co. has a 12-month low of $69.40 and a 12-month high of $123.99. The company has a market capitalization of $3.84 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 1.69 and a beta of 1.16. The firm’s 50-day moving average price is $116.91 and its two-hundred day moving average price is $110.06.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. The business had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $0.87 EPS. On average, analysts forecast that Integer Holdings Co. will post 5.27 earnings per share for the current fiscal year.

Insider Transactions at Integer

In related news, Director James F. Hinrichs sold 9,603 shares of the company’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares in the company, valued at approximately $908,994.56. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director James F. Hinrichs sold 9,603 shares of the business’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the sale, the director now owns 7,424 shares in the company, valued at approximately $908,994.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John A. Harris sold 1,521 shares of the stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total value of $183,189.24. Following the completion of the transaction, the executive vice president now owns 4,922 shares of the company’s stock, valued at $592,805.68. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,936 shares of company stock valued at $2,130,937. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on ITGR shares. CL King began coverage on shares of Integer in a research note on Thursday, March 14th. They set a “buy” rating and a $137.00 target price for the company. Bank of America raised Integer from a “neutral” rating to a “buy” rating and upped their target price for the company from $105.00 to $135.00 in a research report on Monday, April 15th. Citigroup upped their price objective on Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. Truist Financial assumed coverage on shares of Integer in a research report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price for the company. Finally, Benchmark reiterated a “buy” rating and issued a $130.00 price objective on shares of Integer in a research note on Friday, May 10th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $128.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.